Ameeta A. Patel

1.4k total citations
14 papers, 669 citations indexed

About

Ameeta A. Patel is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Ameeta A. Patel has authored 14 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Ameeta A. Patel's work include Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (3 papers) and DNA Repair Mechanisms (2 papers). Ameeta A. Patel is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), RNA modifications and cancer (3 papers) and DNA Repair Mechanisms (2 papers). Ameeta A. Patel collaborates with scholars based in United States, China and Japan. Ameeta A. Patel's co-authors include Jeffrey N. Myers, Abdullah A. Osman, Hideaki Takahashi, Antje Lindemann, Noriaki Tanaka, Mei Zhao, Alison L. Fitzgerald, Mitchell J. Frederick, Yoko Takahashi and Halcyon G. Skinner and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Oncogene.

In The Last Decade

Ameeta A. Patel

14 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ameeta A. Patel United States	10	397	339	162	69	63	14	669
Patrick T. Hennessey United States	13	474 1.2×	118 0.3×	227 1.4×	129 1.9×	92 1.5×	15	775
Xifa Zhou China	16	583 1.5×	190 0.6×	354 2.2×	22 0.3×	104 1.7×	34	817
Kyungmi Yang South Korea	13	254 0.6×	117 0.3×	61 0.4×	25 0.4×	90 1.4×	48	563
Mingjing He China	16	443 1.1×	194 0.6×	95 0.6×	29 0.4×	88 1.4×	26	723
Hao Peng China	15	706 1.8×	150 0.4×	373 2.3×	17 0.2×	118 1.9×	25	939
Jiazhang Wei China	14	324 0.8×	126 0.4×	194 1.2×	48 0.7×	75 1.2×	46	606
Sherianne Ricks United States	7	266 0.7×	195 0.6×	71 0.4×	52 0.8×	52 0.8×	8	524
Mary Luz Uribe Spain	8	259 0.7×	153 0.5×	81 0.5×	24 0.3×	104 1.7×	14	513
C. Papadimitriou Greece	9	203 0.5×	241 0.7×	85 0.5×	24 0.3×	65 1.0×	16	513
Alok Mishra India	7	306 0.8×	116 0.3×	164 1.0×	41 0.6×	39 0.6×	8	488

Countries citing papers authored by Ameeta A. Patel

Since Specialization

Citations

This map shows the geographic impact of Ameeta A. Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ameeta A. Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ameeta A. Patel more than expected).

Fields of papers citing papers by Ameeta A. Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ameeta A. Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ameeta A. Patel. The network helps show where Ameeta A. Patel may publish in the future.

Co-authorship network of co-authors of Ameeta A. Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Ameeta A. Patel. A scholar is included among the top collaborators of Ameeta A. Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ameeta A. Patel. Ameeta A. Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lindemann, Antje, Ameeta A. Patel, Lin Tang, et al.. (2021). Combined Inhibition of Rad51 and Wee1 Enhances Cell Killing in HNSCC Through Induction of Apoptosis Associated With Excessive DNA Damage and Replication Stress. Molecular Cancer Therapeutics. 20(7). 1257–1269. 18 indexed citations

Lindemann, Antje, Hideaki Takahashi, Ameeta A. Patel, et al.. (2020). Abstract PR08: Inhibition of ATR as a therapeutic strategy to overcome cisplatin resistance in HNSCC. Clinical Cancer Research. 26(12_Supplement_2). PR08–PR08. 1 indexed citations

Lindemann, Antje, Ameeta A. Patel, Natalie L. Silver, et al.. (2019). COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms. Clinical Cancer Research. 25(18). 5650–5662. 102 indexed citations

Chari, Nikhil, Cristina Ivan, Jinzhong Li, et al.. (2019). Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer. JNCI Journal of the National Cancer Institute. 112(3). 266–277. 6 indexed citations

Tanaka, Noriaki, Abdullah A. Osman, Yoko Takahashi, et al.. (2018). Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity. Oral Oncology. 87. 49–57. 106 indexed citations

Lindemann, Antje, Hideaki Takahashi, Ameeta A. Patel, Abdullah A. Osman, & Jeffrey N. Myers. (2018). Targeting the DNA Damage Response in OSCC with TP 53 Mutations. Journal of Dental Research. 97(6). 635–644. 115 indexed citations

Lindemann, Antje, Ameeta A. Patel, Hideaki Takahashi, et al.. (2018). COTI-2, a potent orally available small molecule targeting mutant p53, with promising efficacy as monotherapy and combination treatment in preclinical tumor models.. Journal of Clinical Oncology. 36(15_suppl). 6040–6040. 4 indexed citations

Kalu, Nene N., Tuhina Mazumdar, Shaohua Peng, et al.. (2017). Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines. Oncotarget. 8(49). 86369–86383. 43 indexed citations

Tanaka, Noriaki, Mei Zhao, Lin Tang, et al.. (2017). Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1. Oncogene. 37(10). 1279–1292. 41 indexed citations

10.

Silver, Natalie L., Abdullah A. Osman, Ameeta A. Patel, et al.. (2016). A Novel Third Generation Thiosemicarbazone, COTI-2, Is Highly Effective in Killing Head and Neck Squamous Cell Carcinomas (HNSCC) Bearing a Variety of TP53 Mutations. International Journal of Radiation Oncology*Biology*Physics. 94(4). 942–942. 5 indexed citations

11.

Tanaka, Noriaki, Ameeta A. Patel, Jiping Wang, et al.. (2015). Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins. Clinical Cancer Research. 21(21). 4831–4844. 46 indexed citations

12.

Fitzgerald, Alison L., et al.. (2015). Reactive oxygen species and p21Waf1/Cip1 are both essential for p53-mediated senescence of head and neck cancer cells. Cell Death and Disease. 6(3). e1678–e1678. 69 indexed citations

13.

Osman, Abdullah A., Marcus M. Monroe, Marcus V. Ortega Alves, et al.. (2014). Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence. Molecular Cancer Therapeutics. 14(2). 608–619. 88 indexed citations

14.

Bell, James, et al.. (1988). The detection of at‐risk drinking in a teaching hospital. The Medical Journal of Australia. 149(7). 351–355. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact